Holder snapshot 7 signals
Share change
-4,243,522
Put/Call ratio
108%
SEC-reported price per share
$8.85
Indexed holders
431
Value change
-$36,845,034
Number of buys
166
Open additional details 1 more signal available
Number of sells
181
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
1,166,523,868

Security key

881624209

Report period

Q1 2023

Indexed institutions

431

Top holders

10

Ownership snapshot

Top reported holders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Capital Research Global I...
Disclosed value leader
Capital Research Global I...
Comparable rows
0/15
Latest evidence
31 Dec 2022
13F Highest disclosed value: $1,046,926,141 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Capital Research Global Investors has the largest disclosed position value at $1.05B.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Capital Research Global Investors's linked filing trail.
Disclosed position value Top 5
Capital Research Global Investors $1.05B
Capital World Investors $461.14M
BlackRock Finance, Inc. $368.05M
MENORA MIVTACHIM HOLDINGS LTD. $212.17M
Phoenix Financial Ltd. $202.09M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Capital Research Global Investors
13F
Company
13F
—
denominator unverified
$1,046,926,141
114,793,989 shares
— 31 Dec 2022
Capital World Investors
13F
Company
13F
—
denominator unverified
$461,143,561
50,563,987 shares
— 31 Dec 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$368,053,333
40,356,725 shares
— 31 Dec 2022
MENORA MIVTACHIM HOLDINGS LTD.
13F
Company
13F
—
denominator unverified
$212,172,787
23,264,560 shares
— 31 Dec 2022
Phoenix Financial Ltd.
13F
Company
13F
—
denominator unverified
$202,085,985
22,158,551 shares
— 31 Dec 2022
Migdal Insurance & Financial Holdings Ltd.
13F
Company
13F
—
denominator unverified
$196,961,000
21,596,560 shares
— 31 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
431
Shares
558,872,500
Indexed holders
431
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2023 vs Q4 2022 Across Filers

Q4 2022 indexed holders
412
Q1 2023 indexed holders
431
Indexed holder difference
19
Investor Q4 2022 Shares Q1 2023 Shares Share Diff Share Chg % Q4 2022 value Q1 2023 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .